Interleukin-1α Is a Paracrine Inducer of FGF7, a Key Epithelial Growth Factor in Benign Prostatic Hyperplasia

[1]  Downey,et al.  Asymptomatic inflammation and/or infection in benign prostatic hyperplasia , 1999, BJU international.

[2]  M. Ittmann,et al.  FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation. , 1999, The Journal of urology.

[3]  M. Ittmann,et al.  FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells , 1999, Journal of cellular physiology.

[4]  M. Ittmann,et al.  Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  J. Anim,et al.  Characterisation of inflammatory cells in benign prostatic hyperplasia. , 1998, Acta histochemica.

[6]  J. Nemeth,et al.  Keratinocyte growth factor in the rat ventral prostate: androgen-independent expression. , 1998, The Journal of endocrinology.

[7]  H. Lepor,et al.  Morphometric analysis of pediatric and nonhyperplastic prostate glands: Evidence that BPH is not a unique stromal process , 1997, The Prostate.

[8]  M. Ittman,et al.  Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate. , 1997, The Journal of urology.

[9]  N. Kyprianou,et al.  Apoptotic versus proliferative activities in human benign prostatic hyperplasia. , 1996, Human pathology.

[10]  H. Klocker,et al.  Regulation of prostatic growth and function by peptide growth factors , 1996, The Prostate.

[11]  B. A. Gilchrest,et al.  Regulation of keratinocyte growth factor gene expression in human skin fibroblasts. , 1996, Journal of dermatological science.

[12]  C. Lengel,et al.  Cloning and characterization of the promoter region of the human keratinocyte growth factor gene , 1995, The Journal of Biological Chemistry.

[13]  E. Shapiro,et al.  Regional concentration of basic fibroblast growth factor in normal and benign hyperplastic human prostates. , 1995, The Journal of urology.

[14]  Y. Kobayashi,et al.  Selective release of a processed form of interleukin 1 alpha. , 1994, Cytokine.

[15]  S. Werner,et al.  Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. , 1994, Oncogene.

[16]  J. Rubin,et al.  Regulation of keratinocyte growth factor gene expression by interleukin 1. , 1994, The Journal of biological chemistry.

[17]  A. Thomson.  The cytokine handbook , 1994 .

[18]  W. Mckeehan,et al.  Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin. , 1992, Molecular endocrinology.

[19]  C. Eaton,et al.  Regulation of prostate growth. , 1991, The Journal of endocrinology.

[20]  P. Cotton.  Case for prostate therapy wanes despite more treatment options. , 1991, JAMA.

[21]  R J Glynn,et al.  The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. , 1985, American journal of epidemiology.